- Home
- IVP vs APTO Comparison
IVP vs APTO Comparison
Compare IVP & APTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IVP
- APTO
- Stock Information
- Founded
- IVP 2020
- APTO 1986
- Country
- IVP United States
- APTO Canada
- Employees
- IVP N/A
- APTO N/A
- Industry
- IVP Diversified Commercial Services
- APTO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- IVP Miscellaneous
- APTO Health Care
- Exchange
- IVP Nasdaq
- APTO Nasdaq
- Market Cap
- IVP 7.9M
- APTO 7.2M
- IPO Year
- IVP 2023
- APTO N/A
- Fundamental
- Price
- IVP $0.24
- APTO $0.36
- Analyst Decision
- IVP
- APTO Strong Buy
- Analyst Count
- IVP 0
- APTO 3
- Target Price
- IVP N/A
- APTO $6.00
- AVG Volume (30 Days)
- IVP 24.7M
- APTO 70.7K
- Earning Date
- IVP 11-13-2024
- APTO 11-08-2024
- Dividend Yield
- IVP N/A
- APTO N/A
- EPS Growth
- IVP N/A
- APTO N/A
- EPS
- IVP N/A
- APTO N/A
- Revenue
- IVP $17,054,777.00
- APTO N/A
- Revenue This Year
- IVP N/A
- APTO N/A
- Revenue Next Year
- IVP N/A
- APTO N/A
- P/E Ratio
- IVP N/A
- APTO N/A
- Revenue Growth
- IVP 6.12
- APTO N/A
- 52 Week Low
- IVP $0.23
- APTO $0.33
- 52 Week High
- IVP $90.00
- APTO $2.91
- Technical
- Relative Strength Index (RSI)
- IVP 33.74
- APTO 42.90
- Support Level
- IVP $0.23
- APTO $0.35
- Resistance Level
- IVP $0.26
- APTO $0.41
- Average True Range (ATR)
- IVP 0.03
- APTO 0.02
- MACD
- IVP 0.03
- APTO -0.00
- Stochastic Oscillator
- IVP 4.74
- APTO 11.41
About IVP Inspire Veterinary Partners Inc.
Inspire Veterinary Partners Inc owns and operates veterinary hospitals throughout the United States. The company specializes in small animal general practice hospitals that serve all manner of companion pets, emphasizing canine and feline breeds.
About APTO Aptose Biosciences Inc.
Aptose Biosciences Inc is a clinical-stage biotechnology company committed to discovering and developing personalized therapies addressing unmet medical needs in oncology. The Company's small molecule cancer therapeutics pipeline includes products designed to provide single agent efficacy and to enhance the efficacy of other anti-cancer therapies and regimens without overlapping toxicities.